Association between serum fibrinogen levels and diabetic microvascular complications in type 2 diabetes mellitus

Endocrinologist

Volumn 17, Issue 6, 2007, Pages 306-308

  Demirci, Huseyin ^a   Erdamar, Husamettin ^a   Karakoc, Ayhan ^a   Toruner, Fusun Balos ^a   Ozturk, Mehmet Akif ^a   Yetkin, Ilhan ^a   Arslan, Metin ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Diabetic retinopathy; Fibrinogen; Nephropathy; Neuropathy

Indexed keywords

FIBRINOGEN; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; ARTICLE; CLINICAL STUDY; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC MICROANGIOPATHY; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; FIBRINOGEN BLOOD LEVEL; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; STATISTICAL SIGNIFICANCE;

EID: 37349087432     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/TEN.0b013e31815eccca     Document Type: Article

References (10)

1. Igarashi J, Michel T. More sweetness than light? a search for the causes of diabetic vasculopathy. J Clin Invest. 2001;108:1425-1427.
2. Schmidt AM, Yan SD, Wautier JL, et al. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res. 1999;84:489-497.
3. Watts GF, O'Brien SF, Silvester W, et al. Impaired endothelium-dependent and independent dilatation of forearm resistance arteries in men with diet-treated non-insulin-dependent diabetes: role of dyslipidaemia. Clin Sci (Lond). 1996;915:567-573.
4. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia. 1993;36:1119-1125.
5. Bertram B, Wolf S, Kaufhold F, et al. Rheologic findings in patients with diabetic retinopathy. Fortschr Ophthalmol. 1991;88:321-325.
6. Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease: the Framingham study. JAMA. 1987;258:1183-1186.
7. Ernst E. Fibrinogen an important risk factor for atherothrombotic diseases. Ann Med. 1994;26:15-22.
8. Thompson SG, Kienast J, Pyke SD, et al. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med. 1995;332:635-641.
9. Kyung YL, Young HS, Jong SB, et al. Arterial pulsatility as an index of cerebral microangiopathy in diabetes. Stroke. 2000;31:1111-1115.
10. Streja D, Cressey P, Rabkin SW. Associations between inflammatory markers, traditional risk factors, and complications in patients with type 2 diabetes mellitus. J Diabetes Complications. 2003;17:120-127.